InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Perros Manoussos, Chairman & CEO. Officer active across 1 company, notably Entasis Therapeutics Holdings Inc.. Aggregated, 4 disclosures have been recorded. Activity tracked since 19 October 2021. The latest transaction was disclosed on 7 July 2022 (U). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Manoussos Perros is the Chief Executive Officer of Entasis Therapeutics Holdings Inc. He leads the company's operations, focused on developing innovative treatments. His leadership is crucial to the company's mission in the pharmaceutical sector.